KARLIE RYAN: Open Payments
NPI 1306540380 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 27 payments from 9 companies in 2025. Trend: 2023 $1,983 · 2024 $1,819 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $140 |
| Novo Nordisk Inc | 5 | $82 |
| Merck Sharp & Dohme LLC | 5 | $78 |
| GlaxoSmithKline, LLC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| United Therapeutics Corporation | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: VYNDAQEL, Wegovy, VERQUVO, BENLYSTA, WAINUA, Remodulin, JARDIANCE, AMVUTTRA.
Industry payments across AL — which companies pay providers there.
